Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|November 3, 1998
Insulin-like growth factor I (IGF-I) serum level modifications during transdermal estradiol treatment in postmenopausal women: a possible bimodal effect depending on basal IGF-I valuesC Campagnoli, N Biglia, C Cantamessa, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 2000
How to manage the menopause following therapy for breast cancer. is raloxifene a safe alternative?P Sismondi, N Biglia, R Roagna, et al.
Anticancer Research|March 1, 1996
TPS and CA 15.3 serum values as a guide for treating and monitoring breast cancer patientsM Giai, R Roagna, R Ponzone, et al.
Anticancer Research|January 1, 1990
Bone marrow micrometastases detected by a monoclonal antibody in patients with breast cancerM Giai, C Natoli, P Sismondi, et al.
Maturitas|October 9, 1999
HRT, breast and endometrial cancers: strategies and intervention optionsP Sismondi, N Biglia, M Giai, et al.
International Journal of Oncology|May 3, 2011
Clinical and ethical issues in the diagnosis of hereditary breast cancer (review)R Ponzone, M Giai, R Roagna, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 7, 2003
Sentinel node dissection as definitive treatment for node negative breast cancer patientsR Ponzone, N Biglia, F Maggiorotto, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 1, 2005
The influence of hormone replacement therapy on the pathology of breast cancerN Biglia, L Sgro, E Defabiani, et al.
Breast (Edinburgh, Scotland)|June 23, 2018
Feasibility and oncological safety of sentinel node biopsy in breast cancer patients with a local recurrenceN Biglia, V E Bounous, M Gallo, et al.
European Journal of Cancer Care|March 4, 2016
Duloxetine and escitalopram for hot flushes: efficacy and compliance in breast cancer survivorsN Biglia, V E Bounous, T Susini, et al.
Pageof 6